Oneness Biotech Co., Ltd. (TPEX:4743)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
81.60
+0.70 (0.87%)
Feb 21, 2025, 1:30 PM CST
-51.87%
Market Cap 38.96B
Revenue (ttm) 112.20M
Net Income (ttm) -1.26B
Shares Out 477.46M
EPS (ttm) -2.64
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,180,259
Average Volume 2,455,878
Open 81.20
Previous Close 80.90
Day's Range 81.10 - 84.20
52-Week Range 74.30 - 184.00
Beta 1.64
RSI 49.58
Earnings Date Mar 7, 2025

About Oneness Biotech

Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceuticals, and health products primarily in Taiwan. It offers Fespixon cream for diabetic foot ulcers. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials. It is also developing FB825, which is in Phase IIa clinical trial for treating atopic dermatitis and allergic asthma; FB704A that has completed Phase I clinical trial for the tre... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 43
Stock Exchange Taipei Exchange
Ticker Symbol 4743
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.